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Glucose residues from N-linked oligosaccharides are re-
moved by glucosidases I and II in the endoplasmic retic-
ulum (ER) or by the alternate endomannosidase pathway
in the Golgi apparatus. Our morphological analysis demon-
strates that recombinant rat endomannosidase exhibited a
cis- and medial-Golgi localization alike the endogenous en-
zyme and its ER to Golgi transport is COP II mediated. Re-
combinant endomannosidase undergoes a posttranslational
modification, which is not related to N-or O-glycosylation.
A shift in molecular mass of recombinant endomannosi-
dase was observed upon phosphatase digestion but not for
ER-retained CHO cell endomannosidase. Furthermore, im-
munoprecipitation of 35S- and 33P-labeled endomannosidase
expressed in CHO-K1 cells suggests that recombinant en-
domannosidase undergoes phosphorylation. Substitution of
the single cytoplasmic threonine residue of rat endoman-
nosidase by either an alanine or valine residue resulted in
the same posttranslational modification alike the wild-type
enzyme. The subcellular localization and the in vivo activ-
ity of the mutant endomannosidase were not affected. Thus,
endomannosidase phosphorylation is occurring in luminal
sequences. Modification was prevented when endomannosi-
dase was synthesized using reticulocyte lysates in the pres-
ence of canine microsomes. Treatment of cells with brefeldin
A blocked the posttranslational modification of endoman-
nosidase, suggesting that phosphorylation is occurring in
the Golgi apparatus, the residence of endomannosidase.
Keywords: endomannosidase/glucosidase II/Golgi apparatus/
N-glycosylation/phosphorylation
Introduction
Glucose residues from asparagine-linked Glc3Man9GlcNAc2
oligosaccharides are removed by trimming reactions of glu-
cosidases, which are localized in the endoplasmic reticulum
(ER). Their action is important for the biosynthesis of N-linked
oligosaccharides as well as for the quality control of glyco-
protein folding (Parodi 2000; Roth et al. 2002; Helenius and
Aebi 2004). Furthermore, the same oligosaccharide is used as a
1To whom correspondence should be addressed: Tel: +41-1-255-52-36; Fax:
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substrate by endo-α-mannosidase, which provides an alternate
glucosidase-independent pathway of glucose trimming in the
Golgi apparatus (Lubas and Spiro 1987; Spiro et al. 1997; Spiro
2000; Zuber et al. 2000; Roth et al. 2003).
Endomannosidase cleaves the α1,2 linkage between the
glucose-substituted mannose and the remainder mannose branch
of N-glycans. Beside tri-glucosylated oligosaccharides, di- and
mono-glucosylated oligosaccharides are also processed by the
enzyme, even with truncated mannose chains, which are poor
substrates for glucosidase II (Lubas and Spiro 1987, 1988;
Moore and Spiro 1992; Spiro et al. 1997). This unique endo-
glycosidase carries out a substantial amount of de-glucosylation
in vivo as demonstrated by the processing of glycoproteins in
HepG2 cells (Weng and Spiro 1996). In glucosidase II-deficient
Phar2.7 cells (Reitman et al. 1982) or in glucosidase I-deficient
CHO Lec23 cells (Ray et al. 1991; Hong et al. 2004), the pro-
cessing activity of endomannosidase is essential for the mat-
uration of oligosaccharides to hybrid and complex types. Re-
markably, endomannosidase acts on both correctly folded and
misfolded proteins. Thus, it provides a back-up mechanism for
protein N-glycosylation in the Golgi apparatus (Torossi et al.
2006).
Endomannosidase activity is detectable in vertebrate tissues
and in a range of animal and human cell lines (Dairaku and Spiro
1997; Spiro et al. 1997; Dong et al. 2000; Zuber et al. 2000).
Cloning of endomannosidase from various species (Spiro et al.
1997; Hamilton et al. 2005; Torossi et al. 2007) revealed a high
interspecies amino acid sequence identity (Torossi et al. 2007).
Recently, we showed that endomannosidase is an integral type
II membrane protein (Stehli et al. 2008). Moreover, the first 25
N-terminal amino acids, comprising the cytoplasmic tail and the
transmembrane domain are sufficient for Golgi localization of
the enzyme (Stehli et al. 2008). In contrast, glucosidase II is
ER-retained by the β-subunit carrying the C-terminal KDEL re-
trieval sequence (Trombetta et al. 1996; Arendt and Ostergaard
1997; D’Alessio et al. 1999). Hence, distinct mechanisms en-
sure that the glucose-trimming enzymes are located in different
compartments (Zuber et al. 2000; Roth 2002) and fulfill specific
functions.
Glycoproteins bearing monoglucosylated oligosaccharides
will be bound by the chaperone-like lectins calnexin or calretic-
ulin in the ER and released after deglucosylation by glucosidase
II (Roth et al. 2008). On the other hand, by the action of Golgi-
localized endomannosidase, the Man8−5GlcNAc isomer A is
generated which is no more a substrate for re-glucosylation by
UDP-glucose:glycoprotein glucosyltransferase (Parodi 2000).
As a consequence, the enzymatic activity of endomannosidase
in the ER must be inhibited allowing a quality control of glyco-
protein folding and assembly by the calnexin/calreticulin cycle
(Helenius and Aebi 2004).
In the present study, we report the biosynthesis of endoman-
nosidase as well as its ER to Golgi transport. Furthermore, we
c© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org 55
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Fig. 1. Recombinant rat endomannosidase is localized in the Golgi apparatus.
Immunogold labeling for myc-tagged rEndo in the cis- and medial-Golgi
cisternae and in transport vesicles. N nucleus; G Golgi apparatus. Bar 100 nm.
demonstrate that endomannosidase undergoes phosphorylation
in the Golgi apparatus.
Results
ER to Golgi transport of endomannosidase is COP II mediated
Endomannosidase represents a glucose trimming endoglycosi-
dase in the Golgi apparatus and in pre-Golgi intermediates
(Zuber et al. 2000). Double immunofluoresence showed that re-
combinant myc-tagged rat endomannosidase (rEndo) expressed
in CHO-K1 cells and in clone 9 hepatocytes, respectively, re-
tained its inherent Golgi localization (Torossi et al. 2007; Stehli
et al. 2008). By immunoelectron microscopy, the recombi-
nant enzyme was found in the cis- and medial-Golgi appara-
tus and additionally in vesicles (Figure 1). Thus, the recombi-
nant rEndo exhibited a similar subcellular distribution as the
endogenous enzyme (Zuber et al. 2000). In general, transport
between ER and Golgi apparatus is mediated by COPII-coated
vesicles (Hughes and Stephens 2008). We investigated whether
recombinant rEndo, expressed in CHO-K1 cells, is a cargo in
COP II transport vesicles. Indeed, immunoprecipitated sec23
protein complexes contained recombinant rat endomannosi-
dase (rEndo) or rEndo lacking the positively charged amino
acids in the cytoplasmic tail (rEndoR5−7I) (Stehli et al. 2008)
(Figure 2). Hence, the transport of myc-tagged rEndo from ER
to Golgi appears to occur in COP II-vesicles.
Rat endomannosidase is a nonglycosylated protein
To study the biosynthesis of the enzyme, we expressed the
myc-tagged rEndo in CHO-K1 cells as well as in clone 9 rat hep-
atocytes. Immunoprecipitated endomannosidase from metabol-
ically labeled cells showed a time-dependent increase in molec-
ular mass. Initially the enzyme was synthesized as a 53 kDa
protein (Figure 3). After a chase period of 30 min, three bands
with higher molecular mass were observed indicating that rEndo
undergoes a posttranslational modification. After 2 h chase, the
conversion was completed yielding mature rat endomannosi-
dase (rEndom) with molecular mass of 58 and 60 kDa. Both
bands were detectable even after chase periods of up to 24 h
(data not shown). When we expressed the recombinant enzyme
in clone 9 hepatocytes the same increase in molecular mass was
observed. Previously, no consensus Asn-linked glycosylation
Fig. 2. ER to Golgi transport of endomannosidase is COP II-mediated.
Immunoblot analysis of extracts from CHO-K1 cells expressing myc-tagged
rEndo (E). Immunoprecipitated sec23-protein vesicles from CHO-K1 cells
contain myc-tagged rat endomannosidase (rEndo) or myc-tagged rat
endomannosidase R5−7I (rEndo R5−7I). rEndom; mature forms of rat
endomannosidase.
Fig. 3. Rat endomannosidase undergoes a posttranslational modification.
CHO-K1 cells expressing myc-tagged rEndo were pulsed for 20 min and
chased for the time period indicated. Cell lysates (IC) were
immunoprecipitated with anti-myc antibodies and analyzed by 8%
SDS–PAGE/fluorography. The molecular mass of recombinant rEndo
increased time dependently from 53 kDa (0 min) to 58 kDa and 60 kDa
(120 min), respectively. The latter two represent the mature forms of rat
endomannosidase, rEndom.
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Phosphorylation of Golgi endomannosidase
Fig. 4. Rat endomannosidase is phosphorylated. Immunoblot analysis of
CHO-K1 cell extracts expressing Golgi-localized myc-tagged rat
endomannosidase (A), ER-localized myc-tagged CHO cell endomannosidase
(B), or Golgi-localized myc-tagged Thr8Ala-rat endomannosidase (C) in the
absence (−) or presence (+) of phosphatase. Phosphatase treatment results in a
shift of Golgi-localized rat endomannosidases whereas ER-localized CHO cell
endomannosidase is not influenced. rEndom, mature forms of rat
endomannosidase.
sites were identified in the cloned enzyme (Hamilton et al. 2005;
Torossi et al. 2007). Not unexpected, Endo H or PNGase F treat-
ment of mature recombinant rEndo from CHO-K1 cells or from
clone 9 hepatocytes did not reduce its molecular mass (data not
shown). No evidence for the presence of serine/threonine-linked
oligosaccharide side chains on rEndo was obtained by lectin
blot analysis using the Vicia villosa isolectin B4, the Sophora
japonica, the Dolichos biflorus, the Wistaria floribunda, and the
Amaranthus caudatus lectins (Goldstein and Poretz 1986). Fur-
thermore, treatment of CHO-K1 cells expressing rEndo with the
O-glycosylation inhibitor benzyl-GalNac or benzyl-Gal-
GalNac (Ramachandran and Peterkofsky 1997) did not result
in a shift in the molecular mass of recombinant rEndo suggest-
ing that no elongation of O-glycosyl chains occurred (data not
shown). Thus, the posttranslational modification of rEndo is not
related to N- or O-linked glycosylation.
Rat endomannosidase is phosphorylated
To further analyze the nature of the posttranslational modifica-
tion, recombinant rEndo and CHO endomannosidase (Torossi
et al. 2007) were subjected to phosphatase treatment. A shift
in molecular mass was observed for rEndo (Figure 4A and C)
but not for CHO endomannosidase (Figure 4B) upon such a
treatment. Thus, we concluded that rEndo is phosphorylated
either on a single cytoplasmic threonine or on luminal serine,
threonine, or tyrosine residues (Torossi et al. 2007). To sub-
stantiate this finding, we expressed both rEndo and CHO endo-
mannosidase in CHO-K1 cells and labeled these cells for 5 h
with 33P (Figure 5). Immunoprecipitated rEndo was labeled with
33P, indicating that it is modified by phosphate residues (Fig-
ure 5A). In contrast, no 33P incorporation was observed for the
ER-retained CHO endomannosidase (Figure 5B). Furthermore,
no increase in molecular mass was observed when either rEndo
or rEndo lacking its transmembrane domain (TMD-ratEndo)
(Stehli et al. 2008) was synthesized with an in vitro transcrip-
tion/translation system in the presence of canine microsomes
Fig. 5. Only Golgi-localized rat endomannosidase became phosphorylated.
CHO-K1 cells stably expressing either Golgi-localized myc-tagged rEndo
(A) or ER-localized CHO cell endomannosidase (B) were labeled either with
100 μCi/mL 35S or with 700 μCi/mL 33P (see Material and methods).
Myc-tagged endomannosidases were immunoprecipitated from cell lysates
and analyzed by 8% SDS–PAGE/fluorography.
Fig. 6. Posttranslational modification of rat endomannosidase occurs during
passage along the secretory pathway. Immunoblot analysis of extracts from
CHO cells expressing my-tagged rat endomannosidase (E) of rat
endomannosidase (ratEndo) and of rat endomannosidase lacking its
transmembrane domain (TMD-ratEndo), both synthesized in vitro using a
reticulocyte lysate system in the presence of canine microsomes. ratEndom,
mature form of rat endomannosidase.
(Figure 6). However, in vitro synthesis of human α1-antitrypsin
yielded EndoH-sensitive species indicating the occurrence of
posttranslational modification (data not shown). Similarly, the
two bands observed during synthesis of rEndo (Figure 6) might
be due to the cleavage of the signal peptide. Thus, we concluded
that the posttranslational modification of rat endomannosidase
occurs during its passage along the secretory pathway. In or-
der to substantiate that phosphorylation or rEndo might occur
in the Golgi apparatus, we used the drug brefeldin A which
causes the flow back of cis-, medial-, and trans-cisternae of the
Golgi into the ER while leaving the trans-Golgi network intact
(Lippincott-Schwartz et al. 1989). Treatment of CHO-K1 cells
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Fig. 7. Brefeldin A prevents the maturation of endomannosidase. CHO-K1
cells expressing Golgi-localized myc-tagged rEndo were preincubated or not
for 1 h with brefeldin A (2.5 μg/mL), pulsed for 20 min with 35S-methionine,
and chased for the time periods indicated. Cell lysates (IC) were
immunoprecipitated with anti-myc antibodies and analyzed by 8%
SDS–PAGE/fluorography. Brefeldin A blocked the formation of the 58 kDa
and 60 kDa mature form of endomannosidase (rEndom).
with BFA abolished the shift in molecular mass of rEndo (Fig-
ure 7). Hence, phosphorylation occurred in the Golgi apparatus,
the residence of endomannosidase.
Rat endomannosidase is phosphorylated in its luminal domain
By site-directed mutagenesis we replaced the single threonine at
position 8 in the cytoplasmic tail rEndo by either a valine or ala-
nine residue and expressed the mutant proteins in CHO-K1 cells.
Western blot analysis of CHO-K1 cell extracts showed that both
rEndo T8A and T8V undergo the same posttranslational mod-
ification alike the wild-type enzyme (Figure 4C). Phosphatase
treatment of rEndo T8A (Figure 4C) or of rEndo T8V (data not
shown) resulted in a shift in molecular mass alike the wild-type
enzyme (Figure 4A) suggesting that the single threonine residue
in the cytoplasmic tail of rEndo might not be phosphorylated.
Double confocal immunofluorescence showed a Golgi localiza-
tion for rEndo T8A (Figure 8A–C) and for rEndo T8V (data
not shown). Furthermore, both mutant rat endomannosidases
exhibited fully enzymatic activity (Figure 8D) in processing
the N-linked oligosaccharides of α1-antitrypsin (Torossi et al.
2007).
Discussion
In the present study, we showed that recombinant rat endo-
mannosidase (rEndo) exhibited an inherent Golgi localization\
alike the endogenous enzyme (Zuber et al. 2000; Stehli et al.
2008; present study). Thus, the recombinant enzyme seems to
be properly folded in order to exit the endoplasmic reticulum
(ER) (Parodi 2000; Roth et al. 2002; Helenius and Aebi 2004)
whereas recombinant CHO cell endomannosidase was ER re-
tained. Recently, we established the molecular defect in CHO
cell endomannosidase causing its mislocalization and reduced in
vivo activity namely a single Trp188/Cys substitution (Torossi
et al. 2007). The export of proteins from the ER is a highly se-
lective process involving COP II transport vesicles (Hughes and
Stephens 2008). Indeed, our present biochemical data demon-
strate that recombinant rEndo, a type II membrane protein, is
a cargo of the COP II complex. Therefore, we conclude that
ER to Golgi transport of endomannosidase is COP II-mediated.
Several amino acid motifs such as di-acidic, di-hydrophobic,
or di-aromatic sequences were identified to serve as ER export
signals. Recently, another type of ER export signal has been
described consisting of di-basic amino acids, located proximal
to the transmembrane region of Golgi-resident glycosyltrans-
ferase. The interaction of the COP II component Sar1p with the
di-basic motif seems to be a critical selection of type II mem-
brane proteins as cargo of COP II transport vesicles along the
secretory pathway (Giraudo and Maccioni 2003). Cloning of
endomannosidase from various species (Hamilton et al. 2005;
Torossi et al. 2007) showed that they share as a common feature
a cluster of arginine residues in their cytoplasmic tail suggesting
that these positively charged amino acids might act as an ER ex-
port signal. However, substitution of these amino acid residues
by neutral amino acids did not prevent Golgi localization (Stehli
et al. 2008; present study). Thus, not only the positively charged
amino acids but also structural information of the amino acid
side chain influences the ER to Golgi transport competence.
The transport of proteins from the ER to the Golgi apparatus
is often accompanied by various posttranslational modifications
such as glycosylation, phosphorylation, or sulfation. Indeed,
our biochemical analysis demonstrated that recombinant rEndo
undergoes a posttranslational modification, which was not re-
lated to N- or O-glycosylation. Phosphatase treatment and in
vitro phosphorylation experiments showed that the enzyme is
phosphorylated on luminal Ser, Thr, or Tyr residues. However,
alkaline phosphatase treatment did not completely abolish the
increase in molecular mass. Thus, we conclude that rEndo un-
dergoes phosphorylation beside additional modifications, which
remain to be identified. It is well known that various secre-
tory proteins with different biological functions become phos-
phorylated along the secretory pathway (Wang and Williams
1982; Oetting et al. 1986; Gaut and Hendershot 1993; Swift
1996). Amongst Golgi-localized glycosyltransferases, isoforms
of α2,6-sialyltransferase (ST6Gal-I) are phosphorylated on Ser
and Thr residues in their luminal sequences in various cell types
(Ma et al. 1999), whereas Ser residues within the cytosolic tail of
β1,4-galactosyltransferase 1 (GalT) are phosphorylated (Strous
et al. 1987).
The fact that ER retained CHO cell endomannosidase (Torossi
et al. 2007) failed to undergo phosphorylation together with data
obtained from our in vitro transcription/translation system sug-
gested that rat endomannosidase phosphorylation occurred in
a past ER compartment. Using the drug brefeldin A (Fujiwara
et al. 1988; Lippincott-Schwartz et al. 1989), we established the
Golgi apparatus as the site of phosphorylation of rEndo. How-
ever, we cannot exclude the possibility that rEndo undergoes
this posttranslational modification in COP II vesicles. Actually,
kinase activities were not only identified in the lumen of the
ER (Hendershot et al. 1988), but also in the Golgi apparatus
(West and Clegg 1984; Rosa et al. 1992). Moreover, Hirschberg
and colleagues (Capasso et al. 1989) identified a functional ATP
transporter in the Golgi membrane. Recently, a protein kinase,
which phosphorylates serine or threonine residue within atyp-
ical cadherin, was identified in the Golgi apparatus (Ishikawa
et al. 2008). Thus, our work on rEndo provides additional evi-
dence that phosphorylation of secretory proteins does not occur
exclusively in the ER but also in the Golgi apparatus.
Many functions have been attributed to the phoshorylation of
proteins. Cell surface localization and function of GalT was in-
fluenced by this posttranslational modification (Hathaway et al.
2003). For ST6Gal-I, it was hypothesized that phosphorylation
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Fig. 8. Engineered rat Endo T8A expressed in CHO-K1 cells exhibited Golgi localization. Confocal double immunofluorescence for myc-tagged rEndo T8A
(A) and Golgi mannosidase II (B) showed codistribution (C). Bar, 10 μm. Processing of immunoprecipitated α1-antitrypsin by rEndo T8A from CHO Lec23 cells
was analyzed (D). The oligosaccharides of intracellular α1-antitrypsin (IC) were Endo H sensitive, whereas oligosaccharides of secreted α1-antitrypsin (EC) were
fully processed as indicated by Endo H resistance and PNGase F-sensitivity.
controls the trafficking to and/or cleavage within the late Golgi
apparatus or a post-Golgi compartment (Ma et al. 1999). Fur-
thermore, phosphorylation of a single Ser residue in aquaporin
2 by protein kinase A serves as a key signal for its insertion
into the plasma membrane in renal cells (Procino et al. 2003).
Control of enzymatic activity or regulation of a protein half-
life, as observed for many protein kinases, might be another
function of phosphorylation (Hunter 2007). The functional im-
portance of phosphorylation on endomannosidase remains to
be investigated in further studies. However, we speculate that
the enzymatic activity of Golgi endomannosidase might be con-
trolled by phosphorylation. Finally, one also has to consider that
a non-functional phosphorylation can occur (Lienhard 2008).
Material and methods
Antibodies and reagents
The mouse monoclonal anti-myc antibody was from Upstate
(Milton Keynes, UK), the polyclonal anti-myc-, the polyclonal
anti-sec23, and the polyclonal anti-COP II antibody from Ab-
cam (Cambridge, UK). Horseradish peroxidase-conjugated goat
anti-rabbit IgG and goat anti-mouse IgG were purchased from
Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA).
Protease inhibitor tablets, Endo H, PNGase F, and alkaline phos-
phatase from calf intestine were purchased from Roche Diagnos-
tics (Rotkreuz, Switzerland); TNT coupled reticulocyte lysate
systems and canine microsomes from Promega (Wallisellen,
Switzerland); pcDNA6/myc-His, competent E. coli DH5α cells,
lipofectamine 2000, cell culture media and fetal bovine serum
from Invitrogen (Basel, Switzerland). 35S-labeled methionine
was purchased from Anawa Trading SA (Wangen, Switzer-
land) and 33P from GE healthcare (Otelfingen, Switzerland).
Protein A magnetic beads were from Dynal (Hamburg, Ger-
many), biotinylated- or digoxigenin-conjugated lectins, digi-
tonin and all other chemicals of analytical grade from Sigma
(Buchs, Switzerland).
Cell lines and transfection
CHO-K1 cells and clone 9 rat hepatocytes were obtained from
American Type Culture Collection (Manassas, VA) and grown
in Ham’s F12 medium containing 10% fetal bovine serum at
37◦C in a 5% CO2 incubator. The CHO Lec 23 cells (Ray et al.
1991; Hong et al. 2004) were kindly provided by Dr. Pamela
Stanley (New York, NY) and cultured in Eagle’s minimal essen-
tial medium (alpha modification) containing 10% fetal bovine
serum (FBS). Stable transfections were performed as described
previously (Torossi et al. 2007; Stehli et al. 2008).
Site-directed mutagenesis in rat endomannosidase
Mutant rEndo were generated by a PCR-based site-directed
mutagenesis strategy as described (Stehli et al. 2008).
Metabolic labeling, immunoprecipitation, and SDS–PAGE
CHO-K1 cells or clone 9 hepatocytes stably expressing myc-
tagged rEndo (Torossi et al. 2007; Stehli et al. 2008) were in-
cubated in methionine-free DMEM for 30 min at 37◦C in a
5% CO2 incubator. Afterward, cells were labeled in medium
containing 100 μCi/mL 35S-methionine for 20 min and chased
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with medium containing cold methionine (1 mM) for the
indicated time points. Cells treated with brefeldin A (BFA)
were preincubated in medium containing 2.5 μg/mL BFA for
1 h. The same concentration of BFA was maintained through-
out the methionine-depletion, labeling, and chase periods. Cells
were washed with ice-cold phosphate-buffered saline pH 7.4
(PBS), mechanically removed with a rubber policeman and re-
suspended in PBS containing protease inhibitors. Proteins were
extracted with Triton X-100 (1%, 1 h at 4◦C) and cell debris
removed by centrifugation. The cell extracts and the corre-
sponding culture mediums were added to protein A magnetic
beads conjugated with a rabbit anti-myc antibody and incu-
bated for 16 h at 4◦C. Immunoprecipitates were washed with
PBS containing 0.1% Triton X-100 and analyzed by 8% SDS–
polyacrylamide gel electrophoresis (SDS–PAGE).
Combined immunoprecipitations/immunoblot analysis
Immunoprecipitations of myc-tagged rEndo were performed
as described above. For COPII immunoprecipitations, anti-
sec23 antibodies, crosslinked to magnetic beads, were added to
digitonin-lysed cells. Immunoprecipitates and CHO cell extracts
were analyzed by 8% SDS–PAGE and transferred onto nitrocel-
lulose membranes using a semidry blotting apparatus (Towbin
et al. 1979). The nitrocellulose membranes were blocked in
PBS containing 1% BSA for 1 h at ambient temperature and
incubated with a mouse anti-myc antibody, overnight at 4◦C
followed by the incubation with the corresponding horseradish-
conjugated secondary antibody for enhanced chemilumines-
cence detection.
Phosphatase digestion, glycosidase treatment, and lectin
blotting
For phosphatase digestion, CHO-K1 cell extracts were digested
with 2 U alkaline phosphatase for 16 h at 37◦C. The samples
were analyzed by SDS–PAGE/immunoblotting as described
above. Immunoprecipitated myc-tagged rEndo was subjected
to Endo H and PNGase F treatment as described previously
(Torossi et al. 2006). For lectin blotting, the nitrocellulose mem-
branes were either incubated with digoxigenin-conjugated or bi-
otinylated lectins according to the manufacturer’s instructions.
Lectin binding was detected by using alkaline phosphatase-
conjugated polyclonal sheep anti-digoxigenin Fab’ fragments or
alkaline phosphatase-conjugated streptavidin. Enzyme activity
was revealed by using the nitroblue tetrazolium/X-phosphate
substrate system. As control for lectin blotting, nitrocellulose
stripes containing immobilized rat megalin was used (Ziak et al.
1999).
In vivo phosphorylation of rat endomannosidase
For labeling of proteins with 33P, CHO-K1 cells expressing myc-
tagged rEndo or CHO endomannosidase (Torossi et al. 2007;
Stehli et al. 2008) were incubated in DMEM medium without
sodium phosphate for 30 min at 37◦C in a 5% CO2 incubator.
Cells were labeled in medium containing 700 μCi/mL of 33P for
5 h at 37◦C. Lysis of the cells and analysis of the immunopre-
cipitates were performed as described above. Radioactivity was
visualized by autoradiography or by using a phosphorimager
(FUJI Film Corp., Japan).
In vitro transcription and translation
Coupled, nonradioactive in vitro transcription and translation, in
the presence or absence of canine microsomes, was performed
with 1 μg of Fsp I-linearized pcDNA6/rat- or CHO endoman-
nosidase (Torossi et al. 2007) as a template in a total reaction
volume of 25 μL, according to the manufacturer’s instructions.
As a control, 1 μg of Sca I-linearized pcDNA3/α1-antitrypsin
(Torossi et al. 2006) was used. At the end, 5 μL of reaction mix-
tures was analyzed by SDS–PAGE/immunoblotting blotting as
described above.
Confocal immunofluorescence microscopy and in vivo
endomannosidase assay
Transfected CHO-K1 cells grown as a monolayer on glass cover
slips were formaldehyde fixed and saponin permeabilized. Dou-
ble immunolabeling incubations were performed as described
(Stehli et al. 2008). Endomannosidase activity was determined
on the basis of the processing of the oligosaccharides of human
α1-antitrypsin (Stehli et al. 2008).
Immunoelectron microscopy
CHO-K1 cells were fixed in 3% paraformaldehyde in PBS,
embedded in low-melting agarose, and infiltrated with a sucrose-
polyvinol pyrrolidone mixture. Frozen ultrathin cryosections
were prepared according to Tokuyasu (1978, 1980), incubated
with a mouse anti-myc antibody followed by a 8 nm gold-labeled
secondary antibody according to standard protocols (Roth et al.
1978).
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